2m 2m 2m 2m 2m 2m 2m
Ligand Pharma (LGND)
NASDAQ
$278.87+$16.69 (+6.37%)
Price as of Jun 23, 2026 6:55 PM EDT- $5.3BMarket Cap
- 128.02%1-Year Change
- BiotechnologyIndustry
Ligand Pharma (LGND)
$278.87+$16.69 (+6.37%)
Earnings Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 3.93% | ||
12-Month Momentum | 90.89% | ||
3-Month Risk Adjusted Momentum | 19.58% | ||
12-Month Risk Adjusted Momentum | 253.68% |
True Yield
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.38% | ||
Net Debt Paydown Yield | -0.60% |
Financial Health Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |